Your browser is no longer supported. Please, upgrade your browser.
T2 Biosystems, Inc.
Index- P/E- EPS (ttm)-0.68 Insider Own0.30% Shs Outstand147.79M Perf Week-30.13%
Market Cap288.50M Forward P/E- EPS next Y-0.21 Insider Trans-3.53% Shs Float140.78M Perf Month-28.57%
Income-50.90M PEG- EPS next Q-0.07 Inst Own14.50% Short Float6.93% Perf Quarter39.13%
Sales13.40M P/S21.53 EPS this Y-2.80% Inst Trans13.83% Short Ratio0.76 Perf Half Y12.68%
Book/sh0.12 P/B13.33 EPS next Y32.00% ROA-102.00% Target Price- Perf Year210.68%
Cash/sh0.23 P/C7.02 EPS next 5Y- ROE755.30% 52W Range0.23 - 3.79 Perf YTD29.03%
Dividend- P/FCF- EPS past 5Y20.70% ROI-584.90% 52W High-57.78% Beta0.43
Dividend %- Quick Ratio4.60 Sales past 5Y133.90% Gross Margin-25.40% 52W Low580.85% ATR0.38
Employees151 Current Ratio5.00 Sales Q/Q205.90% Oper. Margin- RSI (14)34.10 Volatility15.76% 13.75%
OptionableYes Debt/Eq2.53 EPS Q/Q75.60% Profit Margin- Rel Volume1.85 Prev Close1.95
ShortableYes LT Debt/Eq2.53 EarningsMar 04 AMC Payout- Avg Volume12.80M Price1.60
Recom1.60 SMA20-41.97% SMA50-24.31% SMA2004.95% Volume23,523,976 Change-17.95%
Jan-27-21Downgrade Alliance Global Partners Buy → Neutral $2.60 → $2.40
Oct-08-20Initiated BTIG Research Buy $2.50
Nov-26-19Downgrade Janney Buy → Neutral
Aug-01-19Downgrade Alliance Global Partners Buy → Neutral
Jul-31-19Downgrade Janney Buy → Neutral
Jul-31-19Downgrade H.C. Wainwright Buy → Neutral
May-16-19Initiated Alliance Global Partners Buy $5
Mar-08-19Reiterated H.C. Wainwright Buy $14 → $11
Jun-01-18Upgrade Leerink Partners Mkt Perform → Outperform
May-30-18Reiterated H.C. Wainwright Buy $8.50 → $14
May-29-18Reiterated WBB Securities Strong Buy $12 → $20
Mar-29-18Reiterated H.C. Wainwright Buy $8 → $8.50
Jan-29-18Initiated Goldman Neutral $5.20
Oct-18-17Initiated H.C. Wainwright Buy $8
Mar-15-17Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-10-16Resumed Leerink Partners Mkt Perform $5
Nov-02-16Reiterated Cantor Fitzgerald Buy $10 → $9
Jul-20-16Upgrade WBB Securities Buy → Strong Buy $11 → $12
Jun-22-16Upgrade WBB Securities Speculative Buy → Buy $11
Apr-12-16Reiterated Canaccord Genuity Buy $13 → $12
Mar-04-21 06:25PM  
Feb-23-21 08:00AM  
Feb-08-21 04:07PM  
Feb-05-21 03:53PM  
Feb-04-21 04:05PM  
Jan-29-21 04:05PM  
Jan-27-21 07:35AM  
Jan-26-21 04:45PM  
Jan-12-21 02:06PM  
Jan-11-21 06:19PM  
Jan-07-21 08:00AM  
Dec-31-20 08:42AM  
Dec-30-20 10:28AM  
Nov-28-20 09:03PM  
Nov-12-20 04:32PM  
Nov-10-20 07:38AM  
Nov-09-20 11:23AM  
Nov-04-20 07:05PM  
Oct-28-20 03:30PM  
Oct-19-20 04:42PM  
Oct-14-20 04:05PM  
Oct-08-20 11:30AM  
Sep-30-20 09:00AM  
Sep-22-20 11:30AM  
Sep-16-20 01:11PM  
Sep-04-20 11:30AM  
Sep-01-20 10:10AM  
Aug-31-20 04:05PM  
Aug-26-20 01:08PM  
Aug-25-20 06:19AM  
Aug-24-20 11:12AM  
Aug-18-20 11:30AM  
Aug-11-20 04:49PM  
Aug-10-20 11:08AM  
Aug-05-20 07:30AM  
Jul-31-20 05:45PM  
Jul-30-20 04:05PM  
Jul-28-20 04:05PM  
Jul-24-20 05:45PM  
Jul-07-20 05:50PM  
Jul-02-20 10:12AM  
Jul-01-20 08:12AM  
Jun-30-20 04:06PM  
Jun-26-20 08:00AM  
Jun-24-20 11:30AM  
Jun-17-20 07:30AM  
Jun-15-20 04:06PM  
Jun-08-20 09:18AM  
Jun-05-20 11:30AM  
May-26-20 10:11AM  
May-19-20 08:30AM  
May-17-20 12:22PM  
May-05-20 04:05PM  
Apr-30-20 07:56AM  
Apr-21-20 04:22PM  
Apr-15-20 05:06PM  
Mar-26-20 08:48AM  
Mar-25-20 07:29AM  
Mar-24-20 04:31PM  
Mar-19-20 08:00AM  
Mar-09-20 09:48PM  
Feb-28-20 01:31PM  
Feb-24-20 04:05PM  
Feb-19-20 04:05PM  
Feb-12-20 04:05PM  
Feb-04-20 09:30AM  
Jan-17-20 04:15PM  
Jan-13-20 07:30AM  
Jan-10-20 07:13AM  
Jan-09-20 04:30PM  
Dec-23-19 08:05PM  
Dec-13-19 04:15PM  
Nov-29-19 08:52AM  
Nov-20-19 07:30AM  
Nov-15-19 07:30AM  
Nov-12-19 07:30AM  
Nov-08-19 04:15PM  
Nov-07-19 07:30AM  
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. It provides T2 Magnetic Resonance technology that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument for detecting pathogens associated with sepsis and Lyme disease, and other applications, as well as T2Candida Panel that identifies the species of Candida, a fungal pathogen known to cause sepsis directly from whole blood. In addition, it provides T2Bacteria Panel, a multiplex diagnostic panel that detects various bacterial pathogens associated with sepsis; T2SARS-CoV-2 Panel, a COVID-19 molecular diagnostic test; and T2Resistance Panel for the early and sensitive detection of carbapenemase-resistance markers. Further, it develops T2Cauris Panel, a multi-drug resistant pathogen; and T2Lyme Panel for the detection of various strains of Lyme disease-causing bacteria. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease; and Allergan Sales, LLC to develop detection diagnostic test panel that adds one additional bacteria species to the existing T2Bacteria product candidate, as well as for testing drug resistance directly in whole blood. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gibbs Michael TerrenceGeneral CounselFeb 23Sale2.067,28014,99765,347Feb 23 02:23 PM
Sprague John MChief Financial OfficerFeb 23Sale2.045,25010,71035,485Feb 23 02:19 PM
Barclay AlecChief Operations OfficerFeb 23Sale2.067,28014,99765,247Feb 23 02:14 PM